tradingkey.logo

Zai Lab Presents Positive Phase 1 Data For Zl-1310, A Dll3-Targeted Adc

ReutersJun 2, 2025 12:32 PM

- Zai Lab Ltd 9688.HK:

  • ZAI LAB PRESENTS POSITIVE PHASE 1 DATA FOR ZL-1310, A DLL3-TARGETED ADC, DEMONSTRATING ROBUST ANTI-TUMOR ACTIVITY AND SAFETY IN PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER AT 2025 ASCO ANNUAL MEETING

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI